J&J lowers 2022 revenue and earnings expectations stops giving Covid vaccine sales guidance – CNBC

Johnson & Johnson on Tuesday lowered its full-year sales and earnings outlook, and stopped providing Covid-19 vaccine revenue guidance due to a global supply surplus and demand uncertainty.
J&am… [read more]

Leave a Reply

Your email address will not be published.